Risk of T2 lesions when discontinuing fingolimod: a nationwide predictive and comparative study
Malthe Faurschou Wandall‐Holm(Rigshospitalet), Melinda Magyari(University of Copenhagen), Alex Heick(Copenhagen University Hospital), Annika Reynberg Langkilde(University of Copenhagen), Rolf Pringler Holm(Copenhagen University Hospital)
Cited by 4
Related Papers
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Apparent changes in the epidemiology and severity of multiple sclerosis
|Nature Reviews Neurology|2021|209
Comorbidity in Multiple Sclerosis
|Frontiers in Neurology|2020|204